Clinical Trial Update: KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18) [Phase 2, Phase 3]

View source ↗

Summary

Completed phase 2/3 trial comparing once-daily versus twice-daily lopinavir/ritonavir tablets dosed by weight in HIV-1 infected children (PENTA 18) to assess ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Kaletra (lopinavir)

Snippet

Sponsor: PENTA Foundation | Conditions: Antiretroviral Therapy in HIV-1 Infected Children | Phase 2, Phase 3 | Status: COMPLETED